Table 6.
ROC results of PS, ICv, NICv, and λHUv values differentiating HRT* from TC.
HRT* vs. TC | P | cutoff value | AUC | Sensitivity (%) | Specificity (%) | Accuracy(%) | PPV(%) | NPV(%) |
---|---|---|---|---|---|---|---|---|
PS | 0.019 | <17.40 ml/min/100 g | 0.715 | 88.2 | 48.0 | 64.3 | 53.6 | 92.9 |
ICv | 0.005 | <11.42 × 102 μg/cm3 | 0.849 | 82.4 | 88.0 | 85.7 | 82.4 | 95.7 |
NICv | 0.010 | <0.356 | 0.769 | 47.1 | 100.0 | 78.6 | 100.0 | 73.5 |
λHUv | 0.003 | <1.81 | 0.862 | 82.4 | 88.0 | 85.7 | 82.4 | 95.7 |
ROC, receiver operating characteristic curve; AUC, area under the receiver operating characteristic curve.
PS, permeability surface; IC, iodine concentration; NIC, normalized iodine concentration; λHU, slope of spectral HU curve; V, the optimal venous phase.
NPV, negative predictive value; PPV, positive predictive value.
TC, thymic carcinoma.